Skip to main content
Equibles

Ikarian Capital, LLC

Position in TRAW — Traws Pharma, Inc.

CIK 1778253 DALLAS, TX
Back to TRAW Full portfolio

Position in TRAW

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$401,639
-$839,360 QoQ
Shares Held
478,142
-29.5% QoQ
Ownership
3.11%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#6
of 34 holders
Holding Since
Mar 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TRAW Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. TRAW ranks #86 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 328,635 $43,793,900
2 KOD
Kodiak Sciences Inc.
 1,059,730 $41,287,080
3 ALMS
Alumis Inc.
 870,548 $24,497,220
4 PRAX
Praxis Precision Medicines, Inc.
 72,842 $24,386,773
5 PCVX
Vaxcyte, Inc.
 388,682 $22,594,084
6 CLDX
Celldex Therapeutics, Inc.
 478,500 $17,804,985
7 RCUS
Arcus Biosciences, Inc.
 504,559 $15,555,553
8 RLMD
Relmada Therapeutics, Inc.
 2,148,359 $14,866,644

All Filings in TRAW

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $401,639 478,142
2026-03-31 $1,240,999 678,142
2025-12-31 $766,300 678,142
2025-09-30 $52,712 28,493
2025-06-30 $42,169 28,493
2025-03-31 $65,533 28,493
2024-12-31 $874,617 98,493
2022-03-31 $34,914 18,975
2021-12-31 $38,410 15,063
2021-09-30 $57,691 15,063
2021-06-30 $160,956 23,226